Legacy Bridge’s West Pharmaceutical WST Stock Holding History

Legacy Bridge’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13	Closed	-$3.58K	–	475
2025 Q4	$3.58K	Buy	+13	New	+$3.56K	﹤0.01%	382

Other funds holding WST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legacy Bridge's WST Position: Q1 2026 in Review

Legacy Bridge sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 13 shares — an estimated $3.58K sold.

Legacy Bridge first reported a position in WST in Q4 2025 and held it in 1 quarter. The position peaked at $3.58K in Q4 2025. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

Legacy Bridge reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
Legacy Bridge sold 13 West Pharmaceutical shares in Q1 2026, an estimated $3.58K.
Legacy Bridge first reported a position in West Pharmaceutical in Q4 2025 and held it in 1 quarter.
Legacy Bridge's West Pharmaceutical position peaked at $3.58K in Q4 2025.
753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Legacy Bridge's 13F filing for Q1 2026, filed 14 May 2026.